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Experiences of stigma and discrimination in social and healthcare 
settings among trans people living with HIV in the UK 
The People Living with HIV StigmaSurvey UK 2015 was a community led 
national survey investigating experiences of people living with HIV in the UK in 
the past 12 months. Participants aged 18 and over were recruited through over 
120 cross-sector community organisations and 46 HIV clinics to complete an 
anonymous online survey. Trans is an umbrella term which refers to individuals 
whose current gender identity is different to the gender they were assigned at 
birth. Trans participants self-identified via gender identity and gender at birth 
questions. Descriptive analyses of reported experiences in social and health care 
settings were conducted and multivariate logistic regression analyses were used 
to identify sociodemographic predictors of reporting being treated differently to 
non-HIV patients, and being delayed or refused healthcare treatment in the past 
12 months. 31 out of 1576 participants (2%) identified as trans (19 trans women, 
5 trans men, 2 gender queer/non-binary, 5 other). High levels of social stigma 
were reported for all participants, with trans participants significantly more likely 
to report worrying about verbal harassment (39% vs. 23%), and exclusion from 
family gatherings (23% vs. 9%) in the last 12 months, compared to cisgender 
participants. Furthermore, 10% of trans participants reported physical assault in 
the last 12 months, compared to 4% of cisgender participants. Identifying as trans 
was a predictor of reporting being treated differently to non-HIV patients (48% 
vs. 30%; aOR 2.61, CI 1.06, 6.42) and being delayed or refused healthcare (41% 
vs. 16%; aOR 4.58, CI 1.83, 11.44). Trans people living with HIV in the UK 
experience high levels of stigma and discrimination, including within healthcare 
settings, which is likely to impact upon health outcomes. Trans-specific 
education and awareness within healthcare settings could help to improve service 
provision for this demographic. 
Word count: 291 
Keywords: HIV/AIDS, transgender, trans people, stigma, discrimination, 
healthcare provision. 
Word count: 1,486 
Introduction 
Trans is an umbrella term that refers to people who do not identify with their assigned 
gender and/or traditional culturally bound male-female gender binary (e.g. transgender, 
trans male, trans female, gender queer/ non-binary)(Sevelius, Schelm, & Giambrone, 
2015). The term ‘cisgender’ refers to people who identify with the gender they were 
assigned at birth. The prevalence of trans people in the UK remains unknown, but is 
likely to be similar to other high income countries such as the USA, where an estimate 
0.6% of the population self-identifies as transgender (Flores, Herman, Gates, & Brown, 
2016).   
Globally, trans people face many forms of stigma and discrimination related to 
both gender identity and expression (T. Poteat et al., 2015), and as a result are at greater 
risk of mental health issues, physical abuse, social isolation and economic hardship 
(Herbst et al., 2008). Trans people, especially trans women, are also more vulnerable to 
HIV acquisition, although reliable data on the prevalence of HIV in this population is 
inconsistent (T. C. Poteat, Keatley, Wilcher, & Schwenke, 2016). However, a 
systematic review and meta-analysis estimated that the worldwide HIV prevalence 
among trans women was 19.1% (Baral et al., 2013). Research has suggested that over 
60% of trans men identify as men who have sex with men (MSM) (Bauer, Redman, 
Bradley, & Scheim, 2013), but their inclusion in HIV epidemiology is relatively limited 
(T. Poteat, Scheim, Xavier, Reisner, & Baral, 2016).  
In this study we report on the experiences of stigma and discrimination of people 
living with HIV in the UK in 2015 in a variety of social and healthcare settings.  
Methods 
The People Living with HIV StigmaSurvey UK 2015 recruited participants from over 
120 community organisations and 46 NHS clinics across the UK. Participants were UK 
residents living with HIV, and aged 18 or older. Ethical approval was gained from the 
Brighton and Sussex NHS Research Ethics Committee. Responses were stored securely 
and analysed at Public Health England in accordance with the Data Protection Act 
1998. 
The overall survey covered many aspects of HIV-related stigma, and detailed 
methodology has been previously reported (Crenna-Jennings et al., 2017) (Hibbert et 
al., 2017). Trans participants self-identified by utilising an adapted  two-stage method of 
gender identity monitoring (Sausa, Sevelius, Keatley, Rouse Iñiguez, & Reyes, 2009) 
which included a question on current gender identity (“I am: male, female, trans male, 
trans female, gender queer/non-binary, Prefer not to say, Other”) and a second question 
on gender at birth (“What sex were you assigned at birth? Male, Female, Prefer not to 
say”). Cisgender participants were those whose current gender identity was the same as 
their sex assigned at birth. Trans participants were those who had a different gender 
than their gender assigned at birth, or who identified as trans male, trans female, gender 
queer/non-binary, or other. Participants who responded ‘prefer not to say’ were not 
included.  
Descriptive analyses of reported experiences in social and health care settings 
were conducted stratified by gender identity. Multivariate logistic regression analyses 
were performed to explore the association of sociodemographic factors with reporting 
being treated differently and feeling refused treatment in healthcare settings in the last 
12 months. These analyses excluded the responses to ‘worrying about being treated 
differently’ and ‘avoiding care when needed’ due to their high correlation with the 
outcome variables. All statistical analysis was conducted in STATA 13.1 (StataCorp, 
Texas, USA). 
Results 
Of the 1,576 people who participated in the survey, 31 participants self-identified as 
trans (19 trans women, 5 trans men, 2 gender queer/non-binary, and 5 other). These 31 
participants were grouped for these analyses and are referred to as ‘trans’. Four 
participants did not disclose a gender, and were therefore not included in the analyses. 
Table 1 displays a breakdown of demographics for cisgender and trans participants. 
Notably, there were significant differences in injecting drug use and being paid for sex 
between trans and cisgender participants.  
Table 1. Participant demographics. 
  
Cisgender 
(n=1,541) 
Trans (n=31) 
Variable N % N % 
Gender     
Women 359 23% 19 61% 
Men 1,182 77% 5 16% 
Gender queer / non-binary - - 2 6% 
Other - - 5 16% 
Age group     
18-24 37 2% 2 6% 
25-34 237 15% 3 10% 
35-50 782 51% 15 48% 
>50 401 26% 6 20% 
Missing 84 5% 5 16% 
Ethnicity*     
White British or Irish 973 63% 15 48% 
Other ethnicity 565 37% 15 48% 
Missing 3 0% 1 3% 
Sexuality***     
Men who have sex with men (MSM) / gay 966 63% 4 13% 
Heterosexual  523 34% 14 45% 
Other or preferred not to say 52 3% 13 42% 
Relationship status***     
Living with a partner 554 36% 13 42% 
In a relationship, living separately 240 16% 6 19% 
Relationship with >1 partner 21 1% 5 16% 
No relationship/single 723 47% 5 16% 
Missing 3 0% 2 6% 
Ever injected drug use* 207 13% 9 29% 
       in the past 12 months 69 4% 2 6% 
Ever been paid for sex*** 186 12% 12 39% 
      in the last 12 months***  31 2% 4 13% 
Financial hardship in the last 12 months**     
keeping up with bills 632 41% 10 32% 
keeping up but struggling 714 46% 15 48% 
fallen behind on some or many bills 182 12% 2 6% 
Missing 13 1% 4 13% 
Health     
Year diagnosed*     
In the last year 123 8% 0 0% 
2010-2014 360 23% 7 23% 
2005-2009 390 25% 10 32% 
2000-2004 298 19% 4 13% 
More than 15 years ago 340 22% 6 19% 
Missing 30 2% 4 13% 
Ever diagnosed mental health condition1      
Yes 691 45% 14 45% 
No  676 44% 10 32% 
Missing 174 11% 7 23% 
Current disability2      
Yes 325 21% 5 16% 
No 1,167 76% 24 77% 
Missing 49 3% 2 6% 
Poor self-image in relation to HIV     
Yes 565 37% 11 35% 
No 976 63% 20 65% 
 
Statistical difference between trans and cisgender people. 
* p <0.05 
**p<0.01 
***p<0.001 
Experiences of stigma and discrimination in social settings 
Compared to cisgender people, trans participants were significantly more likely to 
report worrying about verbal harassment, having agreed a job change with their 
manager, and exclusion from family gatherings in the last 12 months (Figure 1). 
                                                 
1 Depression, anxiety, bipolar-disorder, post-traumatic stress disorder, psychosis, or 
schizophrenia 
2 Learning, behavioural, emotional, hearing, visual, speech, or mobility 
Notably, 10% of trans participants reported physical assault in the last 12 months, 
compared to 4% of cisgender participants.  
 
Figure 1. Trans and cisgender participants’ experiences of stigma and discrimination in 
social settings in the past 12 months. 
Statistical difference between trans and cisgender people. 
* p <0.05 
**p<0.01 
 
 Experiences of stigma and discrimination in the healthcare setting 
Compared to cisgender participants, trans participants were significantly more likely to 
avoid care, report being treated differently to non-HIV patients, and feeling delayed or 
refused treatment across healthcare settings in the past 12 months (Figure 2). In the past 
12 months, trans participants were also significantly more likely to report; hearing 
negative comments about people living with HIV from healthcare workers; being given 
the last appointment of the day not by choice; and report disclosure of their HIV status 
without their consent from a health care worker to another healthcare worker (38% vs 
16%, p < 0.001), or to a member of the public (21% vs 7%, p < 0.01). 
 
Figure 2. Comparison of healthcare experiences in the last 12 months between trans and 
cisgender participants. 
Statistical difference between trans and cisgender people. 
* p <0.05 
**p<0.01 
***p<0.001 
  Multivariate analyses were conducted to determine sociodemographic 
predictors associated with reporting being treated differently to non-HIV patients, and 
feeling delayed or refused treatment in the past 12 months (Table 2). Identifying as 
trans, facing financial hardship, and having a negative self-image in relation to HIV 
were the strongest predictors of participants reporting being treated differently across 
healthcare settings. Additionally, identifying as trans, having another ethnicity, facing 
financial hardship, and having a negative self-image in relation to HIV were the 
strongest predictors of participants reporting feeling delayed or refused across 
healthcare setting.
Table 2. A multivariate analysis of predictors of participants reporting being treated differently or feeling refused treatment across healthcare 
settings in the last 12 months. 
          Univariate Adjusted model†     Univariate Adjusted model† 
 Total (n=1,528) 
Reported treated differently 
to non-HIV patients OR (95% CI) aOR (95% CI) Felt refused treatment  OR (95% CI) aOR (95% CI) 
  n % n  %     n  %     
Age group           
<=24 
                  
36  2% 8 22% 0.54 (0.24, 1.22) 0.52 (0.22, 1.22) 7 19% 1.11 (0.47, 2.61) 1.23 (0.49, 3.09) 
25-34 
                
229  15% 64 28% 0.69 (0.50, 0.96)* 0.73 (0.52, 1.05) 37 16% 0.84 (0.56, 1.24) 0.91 (0.59, 1.40) 
35-50 
                
785  51% 274 35% ref. ref. 143 18% ref. ref. 
>50 
                
401  26% 97 24% 0.58 (0.44, 0.76)*** 0.56 (0.41, 0.76)*** 54 13% 0.69 (0.49, 0.97)* 0.66 (0.44, 0.97)* 
Missing 
                  
77  5% 24 31% 1.13 (0.66, 1.94) 0.88 (0.49, 1.59) 13 17% 1.25 (0.65, 2.39) 0.91 (0.45, 1.87) 
Gender           
Cisgender 
             
1,496  98% 453 30% ref.  ref.  241 16% ref.  ref.  
Trans 
                  
29  2% 14 48% 2.95 (1.30, 6.69)** 2.61 (1.06, 6.42)* 12 41% 4.79 (2.13, 10.79)*** 4.58 (1.83, 11.44)** 
Missing 3 0% 0 0%   1 33% 2.39 (0.21, 26.50)   
Ethnicity           
White British or Irish 
                
969  63% 268 28% ref. ref. 132 14% ref. ref.  
Other ethnicity 
                
555  36% 197 36% 1.58 (1.26, 1.98)*** 1.27 (0.95, 1.68) 122 22% 1.98 (1.50, 2.60)*** 1.90 (1.34, 2.68)*** 
Missing 
                    
4  0% 2 50% 4.92 (0.44, 54.46) 3.80 (0.32, 45.37)  0%   
Sexuality           
MSM/gay 
                
952  62% 262 28% ref.  ref.  143 15% ref.  ref.  
Heterosexual  
                
513  34% 181 35% 1.51 (1.20, 1.91)** 1.29 (0.96, 1.74) 94 18% 1.36 (1.02, 1.81)* 0.92 (0.63, 1.34) 
Other 
                  
63  4% 24 38% 1.78 (1.03, 3.07)* 1.47 (0.77, 2.81) 17 27% 2.38 (1.31, 4.33)** 1.36 (0.65, 2.81) 
SES           
Employment status           
Full time 
                
767  50% 216 28% ref.  ref.  108 14% ref.  ref.  
Part time 
                
183  12% 55 30% 1.05 (0.73, 1.49) 0.84 (0.57, 1.24) 33 18% 1.30 (0.84, 2.00) 0.98 (0.61, 1.56) 
Retired 
                  
68  4% 15 22% 0.77 (0.42, 1.42) 1.14 (0.58, 2.24) 8 12% 0.89 (0.41, 1.94) 1.30 (0.56, 3.04) 
Other (casual, unemployed, student) 
                
510  33% 181 35% 1.52 (1.19, 1.94)** 0.96 (0.71, 1.30) 105 21% 1.68 (1.25, 2.27)** 0.91 (0.63, 1.31) 
Living locale size           
Large town or city 
             
1,143  75% 348 30% ref.  195 17% ref.  
Town 
                
308  20% 94 31% 0.93 (0.71, 1.23)  45 15% 0.78 (0.55, 1.12)  
Rural area 
                  
71  5% 25 35% 1.16 (0.70, 1.93)  14 20% 1.12 (0.61, 2.05)  
Missing 
                    
6  0% 0 0%   0 0%   
Financial commitments           
keeping up with bills 
                
627  41% 140 22% ref. ref.  65 10% ref. ref.  
keeping up but struggling 
                
711  47% 240 34% 1.77 (1.38, 2.26)*** 1.50 (1.15, 1.96)** 133 19% 1.98 (1.44, 2.72)*** 1.58 (1.12, 2.23)* 
fallen behind on some or many bills 
                
179  12% 85 47% 3.40 (2.37, 4.87)*** 2.53 (1.70, 3.78)*** 55 31% 4.10 (2.71, 6.22)*** 2.85 (1.80, 4.53)*** 
missing 11                   1% 2 18% 1.28 (0.25, 6.67) 0.77 (0.13, 4.67) 1 9% 1.60 (0.18, 13.88) 0.66 (0.05, 8.09) 
Health           
Year diagnosed           
In the last  year 
                
121  8% 27 22% 0.60 (0.37, 0.97)* 0.57 (0.34, 0.95)* 13 11% 0.53 (0.28, 1.00) 0.50 (0.26, 0.98)* 
2010-2014 
                
360  24% 103 29% 0.85 (0.62, 1.16) 0.85 (0.60, 1.19) 55 15% 0.82 (0.55, 1.21) 0.82 (0.54, 1.25) 
2005-2009 
                
388  25% 122 31% ref. ref. 69 18% ref. ref. 
2000-2004 
                
297 19% 102 34% 1.17 (0.84, 1.42) 1.12 (0.79, 1.59) 52 18% 1.02 (0.68, 1.53) 1.00 (0.65, 1.54) 
More than 15 years ago 343 22% 109 32% 1.00 (0.73, 1.38) 1.10 (0.77, 1.56) 63 18% 1.02 (0.70, 1.50) 1.07 (0.70, 1.63) 
missing 
                  
19  1% 4 21% 1.13 (0.33, 3.95) 0.91 (0.24, 3.47) 2 11% 1.06 (0.22, 5.11) 0.78 (0.14, 4.21) 
Ever mental health condition           
Yes 
                
691  45% 229 33% 1.16 (0.92, 1.46) 0.86 (0.65, 1.13) 134 19% 1.35 (1.02, 1.80)* 0.97 (0.70, 1.37) 
No  
                
661  43% 197 30% ref.  ref.  99 15% ref.  ref.  
missing 
                
176  12% 41 23% 0.71 (0.48, 1.05) 0.67 (0.44, 1.02) 21 12% 0.77 (0.46, 1.27) 0.76 (0.44, 1.30) 
Ever physical health condition           
Yes 782 51% 257 33% 1.17 (0.92, 1.49)  137 17% 1.03 (0.77, 1.37)  
No  
                
570  37% 169 30% ref.   96 18% ref.   
missing 
                
176  12% 41 23% 0.72 (0.48, 1.07)  21 12% 0.66 (0.40, 1.10)  
PHQ2           
Low 
             
1,091  71% 300 28% ref. ref. 147 13% ref. ref. 
High 
                
416  27% 163 39% 1.82 (1.43, 2.32)*** 1.14 (0.85, 1.54) 104 25% 2.23 (1.68, 2.97)*** 1.40 (0.99, 1.99) 
missing 
                  
21  1% 4 19% 1.41 (0.41, 4.84) 1.35 (0.36, 5.11) 3 14% 2.25 (0.59, 8.57) 2.37 (0.55, 10.12) 
Disability           
Yes 
                
323  21% 118 37% 1.39 (1.07, 1.81)* 1.27 (0.92, 1.75) 75 23% 1.70 (1.25, 2.30)** 1.48 (1.02, 2.15)* 
No 
             
1,156  76% 340 29% ref. ref. 176 15% ref. ref. 
missing 
                  
49  3% 9 18% 0.58 (0.28, 1.23) 0.69 (0.32, 1.51) 3 6% 0.41 (0.12, 1.33) 0.46 (0.14, 1.57) 
Poor self-image           
Yes 
                
556  64% 222 40% 2.09 (1.67, 2.63)*** 2.02 (1.54, 2.65)*** 126 23% 1.99 (1.51, 2.61)*** 1.62 (1.17, 2.26)** 
No 
                
972  36% 245 25% ref. ref.  128 13% ref. ref.  
Injecting drug use past 12 months           
Yes 
                
69  5% 21 30% 0.96 (0.57, 1.64)  11 16% 0.92 (0.47, 1.78)  
No / Not reported 
             
1,459  95% 446 31% ref.  243 17% ref.  
Been paid for sex past 12 months           
Yes 
                
34  2% 15 44% 1.85 (0.92, 3.75)  8 24% 1.55 (0.69, 3.49)  
No / Not reported 
             
1,494  98% 452 30% ref.   246 16% ref.   
* p <0.05 
**p<0.01 
***p<0.001 
† including age, gender, ethnicity, sexuality, employment status, financial commitments, year diagnosed, ever mental health condition, PHQ2, 
disability, poor self-image 
Discussion 
The findings indicate that trans people perceive and experience different levels of 
stigma and discrimination compared to their cisgender counterparts. Within healthcare 
settings, compared to cisgender participants, trans participants were more likely to 
report incidences of discrimination in healthcare, and in the multivariate analyses, 
identifying as trans was a predictor of reporting being treated differently to non-HIV 
patients, and feeling delayed or refused treatment. Not all stigma and discrimination 
faced by trans people was identified as HIV related. These findings are in agreement 
with previous studies not specific to HIV which indicated that trans people in the UK 
experience high levels of silent harassment (e.g. being started at, whispered about etc.), 
verbal harassment, and physical violence (McNeil, Bailey, Ellis, Morton, & Regan, 
2012; T. Poteat et al., 2015). 
Our findings highlighted several risk factors among trans people that increase 
the likelihood of HIV acquisition, such as a history of transactional sex and injecting 
drug use. Future sexual health promotion messages need to be trans inclusive to target 
this often overlooked population.  Four out of five trans men in our research identified 
as MSM, which highlights the importance of the inclusion of trans men in sexual health 
promotion messages targeted at MSM.  
In Canada and the USA, barriers for accessing care for HIV-positive trans 
people include a lack of appropriate skill, knowledge and training of healthcare 
providers (Bauer et al., 2009; Thornhill & Klein, 2010; Wilson et al., 2009). This 
research would suggest a similar problem in the UK in terms of accessing services, as 
identifying as trans was a significant predictor of participants reporting being treated 
differently compared to non-HIV patients, as well as being delayed or refused treatment 
in the last 12 months.  
The sample of trans people in our study was small, and comparisons within the 
trans community could not be investigated. The experiences of stigma and 
discrimination reported by participants were self-reported and may be subject to recall 
bias and/or selection bias. There was no attempt to validate participants’ responses, 
however, the fact that these experiences are reported suggests that people living with 
HIV continue to face stigma, regardless of whether it was experienced or anticipated. 
Additionally, this is the first study to measure the experiences of trans people living 
with HIV in the UK, and the project had community involvement throughout the 
questionnaire development, analysis and dissemination of results, to ensure 
representation of the communities involved.    
Our findings call for increased awareness and training of healthcare staff around 
trans issues, and the inclusion of trans/non-binary issues in clinical training 
programmes. The level of complexity and the high prevalence of additional risk 
behaviours (higher rates of injecting drug use, experiences of transactional sex etc.) also 
highlight the need for health services working with trans people living with HIV to be 
able to work address multiple and complex needs.   
Future research could further explore the interlinked factors leading to stigma 
and discrimination for trans people. Such research should be trans inclusive, not only 
because of the increased risk of HIV and other sexual health issues within the 
community, but also to further advance trans rights and promote greater understanding 
and representation of trans people in the wider community. Trans people should be 
included in all areas of research where gender information is collected, so that trans 
experiences are acknowledged, and results can then be used to further structural changes 
which will result in greater societal inclusion. 
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